With so many new solutions and other technologies appearing in the clinical trials space, how are stakeholders choosing which ones are best for them and how are these advancements translating to the actual clinic?
Rinol Alaj, senior director, head of clinical outcomes assessment & patient innovation at Regeneron and Jaclyn Patterson, head, clinical trial management & site head, Basking Ridge, also with Regeneron speak to advancements in the clinical trials space, specifically the use of biomarkers and how the benefits of new solutions are transferring to the clinic.
About the speakers
Rinol and Jaclyn have both been with Regeneron for over six years. Prior to their time with Regeneron, they both spent time with Merck. Jaclyn for over 16 years and Rinol for seven. Jaclyn earned her bachelor of science degree in biochemistry from Stockton in New Jersey and Rinol has a bachelor’s and master’s degree in computer science and an MBA in business administration; all from the New Jersey Institute of Technology. Rinol also has an MPH in epidemiology and biostatistics from CUNY.
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.